Application
MOCS2 Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the MOCS2 antibody detected the MOCS2 protein (arrow).| Product Name | MOCS2 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MOCS2; MCBPE; MOCO1; Molybdopterin synthase catalytic subunit; MOCO1-B; Molybdenum cofactor synthesis protein 2 large subunit; Molybdenum cofactor synthesis protein 2B; Molybdopterin-synthase large subunit |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | MCBPE MOCO1 |
|---|---|
| Alternative Names | MOCS2 MCBPE MOCO1 Molybdopterin synthase catalytic subunit MOCO1-B Molybdenum cofactor synthesis protein 2 large subunit Molybdenum cofactor synthesis protein 2B Molybdopterin-synthase large subunit |
| Molecular Weight(MW) | 20944 Da |
| Function | Catalytic subunit of the molybdopterin synthase complex, a complex that catalyzes the conversion of precursor Z into molybdopterin. Acts by mediating the incorporation of 2 sulfur atoms from thiocarboxylated MOCS2A into precursor Z to generate a dithiolene group |
| Tissue Specificity | Highest levels are found in heart and skeletal muscle. Lower levels are present in brain, kidney and pancreas Very low levels are found in lung and peripheral blood leukocytes |
| Cellular Localization | Cytoplasm, cytosol. |
| Entrez Gene | 4338 |
|---|---|
| Nucleotide Accession | NP_004522.1 |
Application
MOCS2 Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the MOCS2 antibody detected the MOCS2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
